PREVIOUS
✖
Compound 3b
August 20 , 2025
17 hrs 0 min
11
0
- Researchers at IIT-Roorkee discovered Compound 3b to fight drug-resistant bacteria.
- Compound 3b works with Meropenem to treat KPC-2 Klebsiella pneumoniae infections.
- It acts as a β-lactamase inhibitor, blocking enzymes that degrade antibiotics.
- KPC-2 is a superbug listed among the WHO's top-priority health threats.
- The discovery targets antimicrobial resistance (AMR), a growing global threat.
Leave a Reply
Your Comment is awaiting moderation.